Lv1
90 积分 2026-02-08 加入
Complex pathways to ceftolozane-tazobactam resistance in clinical Pseudomonas aeruginosa isolates: a genomic epidemiology study
2个月前
已完结
How do I manage difficult-to-treat Pseudomonas aeruginosa infections? Key questions for today’s clinicians
2个月前
已完结
Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli
2个月前
已完结
Ceftolozane/Tazobactam: A Review in Complicated Intra-Abdominal and Urinary Tract Infections
2个月前
已完结
New antibiotics for Gram-negative pneumonia
2个月前
已完结
Cefepime–Taniborbactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination
3个月前
已完结
New β-Lactam–β-Lactamase Inhibitor Combinations
3个月前
已完结
Effectiveness of ceftazidime–avibactam versus ceftolozane–tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study
3个月前
已完结
皖公网安备34019202002308
